SoftBank has led the series E round, doubling MIT Media Labs spinout Formlabs’ valuation to $2bn in the process.

The industrial supplies provider has secured $220m overall after a series E round backed by Harvard Management Company.

Advancing Harvard Medical School research, Dyno Therapeutics has raised $100m to advance its gene therapies based on AAV.

GV, Mass General Brigham Ventures and Lonza helped Affinia Therapeutics raise $110m to commercialise work originating at Harvard.

CU Boulder’s solid-state battery provider pulled in funding through a series B round co-led by potential customers BMW and Ford.

Less than two months after closing a $100m series C round, the Dundee spinout has raised $225m in a series D led by SoftBank Vision Fund 2.

General Motors led a series D round for the lithium-metal battery technology spinout of MIT formerly known as SolidEnergy Systems.

RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.

RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.